MATTHEW D PERRY
CIK 1454337 · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.19M
Companies
3
Total Filings
22
Lifetime Open-Market Net
$5.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-15 | XOMA | Buy (P) | +200,000 | $5.00M | EDGAR |
| 2020-05-27 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2019-05-20 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-20 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2017-05-02 | CTI BIOPHARMA CORP (CTIC) Delisted | Exer (M) | +34,736 | $0 | EDGAR |
| 2017-03-07 | XOMA | Grant (A) | +11,799 | $0 | EDGAR |
| 2017-02-27 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-13 | CTI BIOPHARMA CORP (CTIC) Delisted | Exer (M) | +8,403 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.